BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38090966)

  • 1. Pneumothorax in lung metastasis of advanced soft tissue sarcoma patients treated with oral pazopanib.
    Sarkar S; Mishra PK; Mukhopadhyay S; Sen S; Biswas B
    Indian J Cancer; 2023 Sep; ():. PubMed ID: 38090966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis.
    Nakano K; Motoi N; Tomomatsu J; Gokita T; Ae K; Tanizawa T; Matsumoto S; Takahashi S
    BMC Cancer; 2016 Sep; 16(1):750. PubMed ID: 27663525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series.
    Verschoor AJ; Gelderblom H
    Clin Sarcoma Res; 2014; 4():14. PubMed ID: 25302110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.
    Nakamura T; Matsumine A; Kawai A; Araki N; Goto T; Yonemoto T; Sugiura H; Nishida Y; Hiraga H; Honoki K; Yasuda T; Boku S; Sudo A; Ueda T
    Cancer; 2016 May; 122(9):1408-16. PubMed ID: 26970174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: A case series analysis.
    Aiba H; Kimura H; Yamada S; Okamoto H; Hayashi K; Miwa S; Kawaguchi Y; Saito S; Sakai T; Tatematsu T; Nakanishi R; Murakami H
    PLoS One; 2021; 16(7):e0254866. PubMed ID: 34270626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumothorax during Pazopanib Treatment in Patients with Soft-Tissue Sarcoma: Two Case Reports and a Review of the Literature.
    Nakahara Y; Fukui T; Katono K; Nishizawa Y; Okuma Y; Ikegami M; Sasaki J; Masuda N
    Case Rep Oncol; 2017; 10(1):333-338. PubMed ID: 28559816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pneumothorax during Pazopanib Therapy in a Patient with Soft Tissue Sarcoma].
    Kanno N; Nakahashi K; Shiikawa M; Endo M; Numahata K; Shiono S
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):975-977. PubMed ID: 34267040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of bilateral spontaneous pneumothorax during pazopanib therapy for pulmonary soft tissue sarcoma metastases. What to do when there is so few evidence?].
    Agrafiotis AC; Prieto M; Verhaeghe JL; Siat J; Grosdidier G; Rios M
    Rev Pneumol Clin; 2016 Oct; 72(5):293-295. PubMed ID: 27561973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib.
    Endo M; Kataoka T; Fujiwara T; Tsukushi S; Takahashi M; Kobayashi E; Yamada Y; Tanaka T; Nezu Y; Hiraga H; Wasa J; Nagano A; Nakano K; Nakayama R; Hamada T; Kawano M; Torigoe T; Sakamoto A; Asanuma K; Morii T; Machida R; Sekino Y; Fukuda H; Oda Y; Ozaki T; Tanaka K
    BMC Cancer; 2023 Mar; 23(1):219. PubMed ID: 36890471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
    Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
    Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pazopanib in rare histologies of metastatic soft tissue sarcoma.
    Kataria B; Sharma A; Biswas B; Bakhshi S; Pushpam D
    Ecancermedicalscience; 2021; 15():1281. PubMed ID: 34824604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case Report of Secondary Simultaneous Bilateral Pneumothorax Due to Pazopanib Treatment.
    Çelik B; Sürücü ZP; Yılmaz V; Çelik HK
    Turk Thorac J; 2018 Jan; 19(1):49-51. PubMed ID: 29404187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study.
    Oh CR; Hong JY; Kim JH; Lee JS; Kim HS; Kim TW; Ahn JH; Kim JE
    Target Oncol; 2020 Aug; 15(4):485-493. PubMed ID: 32607656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of pazopanib as a second-line treatment and beyond for soft tissue sarcomas: A real-life tertiary-center experience in the MENA region.
    Halim NA; Sayed RE; Alameh IA; Khoury J; Nakib CE; Zerdan MB; Charafeddine M; Farhat F; Karak FE; Assi HI
    Cancer Treat Res Commun; 2021; 26():100275. PubMed ID: 33340905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral metronomic chemotherapy is a cost effective alternative to pazopanib in advanced soft tissue sarcoma.
    Sharma A; Kataria B; Biswas B; Bakhshi S; Pushpam D
    J Oncol Pharm Pract; 2022 Apr; 28(3):560-568. PubMed ID: 33719725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumothorax as an Adverse Event in Patients with Lung Metastasis of Soft Tissue Sarcoma under Eribulin Treatment.
    Takada K; Murase K; Nakamura H; Hayasaka N; Arihara Y; Iyama S; Ikeda H; Emori M; Sugita S; Nakamura K; Miyanishi K; Kobune M; Kato J
    Intern Med; 2019 Oct; 58(20):3009-3012. PubMed ID: 31243217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study.
    Sabath B; Muhammad HA; Balagani A; Ost DE; Vakil E; Ahmed T; Vial MR; Grosu HB
    BMC Cancer; 2018 Oct; 18(1):937. PubMed ID: 30285733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pazopanib monotherapy in the treatment of pretreated, metastatic uterine sarcoma: a single-center retrospective study.
    Kim HJ; Kim Y; Lee SJ; Lee J; Park SH
    J Gynecol Oncol; 2018 Jan; 29(1):e3. PubMed ID: 29185261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy.
    Touati N; Schöffski P; Litière S; Judson I; Sleijfer S; van der Graaf WT; Italiano A; Isambert N; Gil T; Blay JY; Stark D; Brodowicz T; Marréaud S; Gronchi A
    Clin Oncol (R Coll Radiol); 2018 Jul; 30(7):448-454. PubMed ID: 29550245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043).
    Sleijfer S; Ray-Coquard I; Papai Z; Le Cesne A; Scurr M; Schöffski P; Collin F; Pandite L; Marreaud S; De Brauwer A; van Glabbeke M; Verweij J; Blay JY
    J Clin Oncol; 2009 Jul; 27(19):3126-32. PubMed ID: 19451427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.